DeepMed Research

UNIVERSITY OF NORTH CAROLINA HOSPITALS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1989-01-01

Employees: -

Market Cap: -

Website: http://www.unc.edu/interactive-tour/unc-hospitals/

Clinical Trials

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

Phase 1

Recruiting

Conditions: Ovary Neoplasm
Epithelial Ovarian Cancer
Ovarian Cancer
Recurrent

Interventions: Biological: iC9-CAR.B7-H3 T cells
Drug: Cyclophosphamide
Drug: Fludarabine

First Posted Date: 2024-03-12

Last Posted Date: 2024-10-26

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 27

Registration Number: NCT06305299

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

UNC Metastatic Cancer Radiation Therapy Registry

Recruiting

Conditions: Metastatic Cancer
Cancer

Interventions: Radiation: Radiation therapy

First Posted Date: 2024-03-12

Last Posted Date: 2025-05-01

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 2000

Registration Number: NCT06306924

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

Not Applicable

Recruiting

Conditions: Blood Cancers
Leukemia
Multiple Myeloma
Hematologic Malignancies
Lymphoma

Interventions: Behavioral: Preference Reporting to Improve Management and Experience (PRIME)

First Posted Date: 2024-03-06

Last Posted Date: 2025-01-27

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 500

Registration Number: NCT06296368

Locations: 🇺🇸
Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill, North Carolina, United States

Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia

Not Applicable

Not yet recruiting

Conditions: Head and Neck Cancer
Oropharynx Cancer
Xerostomia

Interventions: Radiation: experimental radiotherapy
Radiation: standard radiotherapy

First Posted Date: 2024-02-26

Last Posted Date: 2025-02-25

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 98

Registration Number: NCT06276946

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill, North Carolina, United States

Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya

Phase 1

Not yet recruiting

Conditions: Cervix; Intraepithelial Neoplasia, Grade II
Cervix Cancer
Cervix; Intraepithelial Neoplasia, Grade I
Cervix Intraepithelial Neoplasia Grade 3

Interventions: Drug: Artesunate pessary
Diagnostic Test: blood draws for pharmacokinetics of the study drug

First Posted Date: 2024-02-16

Last Posted Date: 2024-07-10

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 16

Registration Number: NCT06263582

Locations: 🇰🇪
Lumumba Sub-County Hospital, Kisumu, Kenya

Promoting CT Engagement for Pancreatic Cancer With App

Not Applicable

Recruiting

Conditions: Pancreas Cancer

Interventions: Behavioral: feedback
Behavioral: semistructured interviews

First Posted Date: 2024-02-09

Last Posted Date: 2025-05-13

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 26

Registration Number: NCT06252545

Locations: 🇺🇸
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
🇺🇸
Medical College Of Wisconsin, Milwaukee, Wisconsin, United States

Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors

Not Applicable

Active, not recruiting

Conditions: Physical Activity
Cancer
Cancer Survivorship
Mental Health
Obesity

Interventions: Behavioral: AYA Connect intervention
Behavioral: Positive Psychology (PP) intervention
Behavioral: Positive Psychology Plus (PP+) intervention

First Posted Date: 2023-12-15

Last Posted Date: 2025-05-20

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 77

Registration Number: NCT06171945

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States

Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya

Phase 1

Recruiting

Conditions: Cervix Neoplasm
Precancerous Conditions
Cervix Cancer
Cervical Precancer

Interventions: Drug: Artesunate pessary
Procedure: Colposcopy

First Posted Date: 2023-12-11

Last Posted Date: 2025-04-15

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 18

Registration Number: NCT06165614

Locations: 🇰🇪
Lumumba Sub-County Hospital, Kisumu, Kenya

Autologous CAR-T Cells Targeting B7-H3 in PDAC

Phase 1

Recruiting

Conditions: Relapse
Resistant Cancer
Pancreas Cancer

Interventions: Biological: iC9-CAR.B7-H3 T cell infusion

First Posted Date: 2023-12-06

Last Posted Date: 2025-03-18

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 27

Registration Number: NCT06158139

Locations: 🇺🇸
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment

Not Applicable

Recruiting

Conditions: Breast Cancer
Colorectal Cancer
Cancer

Interventions: Behavioral: Weekly Survey

First Posted Date: 2023-10-24

Last Posted Date: 2025-01-30

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 240

Registration Number: NCT06096623

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy